These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38024830)

  • 21. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
    Barros MH; Hassan R; Niedobitek G
    Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.
    Nakhoul H; Lin Z; Wang X; Roberts C; Dong Y; Flemington E
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31292228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathologic features and association with Epstein-Barr virus infection in 235 cases of Hodgkin lymphoma from northern China].
    Shi Y; Li X
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):84-9. PubMed ID: 25916637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis.
    Özdemir S; Ton Ö; Kabukcuoğlu F
    Turk J Med Sci; 2022 Aug; 52(4):1013-1021. PubMed ID: 36326378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil.
    Assis MC; Campos AH; Oliveira JS; Soares FA; Silva JM; Silva PB; Penna AD; Souza EM; Baiocchi OC
    Med Oncol; 2012 Dec; 29(5):3614-9. PubMed ID: 22791223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.
    Carbone A; Gloghini A; Caruso A; De Paoli P; Dolcetti R
    Int J Cancer; 2017 Mar; 140(6):1233-1245. PubMed ID: 27750386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and characterization of a novel Hodgkin lymphoma cell line, AM-HLH, carrying the Epstein-Barr virus genome integrated into the host chromosome.
    Hayashida M; Daibata M; Tagami E; Taguchi T; Maekawa F; Takeoka K; Fukutsuka K; Shimomura D; Hayashi T; Iwatani Y; Ohno H
    Hematol Oncol; 2017 Dec; 35(4):567-575. PubMed ID: 27813134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
    Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkin lymphoma: prognostic implications.
    Martín P; Salas C; Provencio M; Abraira V; Bellas C
    Leuk Lymphoma; 2011 Nov; 52(11):2162-8. PubMed ID: 21749309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
    Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
    Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
    Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
    J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
    Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
    Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hodgkin's disease and Epstein-Barr virus].
    Depil S; Moralès O; Auriault C
    Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
    Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
    Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
    Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
    Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.
    Xiong J; Dai YT; Wang WF; Zhang H; Wang CF; Yin T; Cheng S; Zhong HJ; Yu SH; Jiang L; Wang SY; Fang H; Zhang RH; Zhu Y; Yi HM; Jiang XF; Chen JY; Wang L; Xu PP; Chen SJ; Zhao WL
    Sci Bull (Beijing); 2023 Nov; 68(21):2607-2619. PubMed ID: 37798178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
    Carbone A; Gloghini A; Carlo-Stella C
    Blood; 2018 Jul; 132(1):17-22. PubMed ID: 29716887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis.
    Piris MA; Medeiros LJ; Chang KC
    Pathology; 2020 Jan; 52(1):154-165. PubMed ID: 31699300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.